Most recent articles by:

Mohsin Riaz

- Advertisement -

AstraZeneca’s Andexxa succeeds in postmarket study, aims for full approval

AstraZeneca’s Andexxa has reached the endpoint of its study  has made the decision to terminate its postmarketing study of the bleeding reversal...

Moderna skin cancer medication gets FDA approval

Moderna announced that U.S. authorities have approved its experimental personalised skin cancer vaccine Keytruda, which is a breakthrough medication as an additional...

Alcon to Pay Johnson & Johnson $199M to Settle Eye-Laser Cases

Alcon and Johnson & Johnson's (J&J) eye care division have reached a settlement over a lawsuit involving femtosecond laser-assisted cataract surgery equipment,...

Summit makes a $5B bet on Akenso’s bispecific antibody to be fruitful

Summit Therapeutics has put its money where its mouth is and bet an astounding $5B bet on Akesio’s bispecific antibody. It includes...

Merck partner NGM biopharmaceuticals’ eye drug unsuccessful in Phase 2 clinical trials

NGM biopharma developed an experimental medication for eye diseases that failed the phase 2 testing, leading to an all-time low share price...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm
- Advertisement -